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Abstract
Background: Larvae of several common species of parasitic nematodes obligately migrate
through, and often damage, host lungs. The larvae induce strong pulmonary Type 2 immune
responses, including T-helper (Th)2 cells as well as alternatively activated macrophages (AAMφ) and
associated chitinase and Fizz/resistin family members (ChaFFs), which are thought to promote
tissue repair processes. Given the prevalence of systemic or lung-resident Type 1-inducing
pathogens in geographical areas in which nematodes are endemic, we wished to investigate the
impact of concurrent Type 1 responses on the development of these Type 2 responses to
nematode larval migration. We therefore infected BALB/c mice with the nematode Nippostrongylus
brasiliensis, in the presence or absence of Plasmodium chabaudi chabaudi malaria parasites. Co-
infected animals received both infections on the same day, and disease was assessed daily before
immunological measurements were taken at 3, 5, 7 or 20 days post-infection.
Results: We observed that the nematodes themselves caused transient loss of body mass and red
blood cell density, but co-infection then slightly ameliorated the severity of malarial anaemia. We
also tracked the development of immune responses in the lung and thoracic lymph node. By the
time of onset of the adaptive immune response around 7 days post-infection, malaria co-infection
had reduced pulmonary expression of ChaFFs. Assessment of the T cell response demonstrated
that the Th2 response to the nematode was also significantly impaired by malaria co-infection.
Conclusion: P. c. chabaudi co-infection altered both local and lymph node Type 2 immune
activation due to migration of N. brasiliensis larvae. Given recent work from other laboratories
showing that N. brasiliensis-induced ChaFFs correlate to the extent of long-term lung damage, our
results raise the possibility that co-infection with malaria might alter pulmonary repair processes
following nematode migration. Further experimentation in the co-infection model developed here
will reveal the longer-term consequences of the presence of both malaria and helminths in the lung.
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Many prevalent species of parasitic nematodes - such as
Ascaris lumbricoides, which infects over a billion people
[1], or Necator americanus, the most geographically wide-
spread of the human hookworms [2] - migrate through
host lungs as larvae. Lung tissue is ruptured as the larvae
burst out of the blood vessels to enter the alveolar spaces.
Although this process is typically asymptomatic in
humans, it can also be associated with acute respiratory
distress or longer term complications [3]. For example,
infection with lung-migrating helminths has been associ-
ated with bronchial hyper-reactivity and other asthma
symptoms among children in China [4] and Brazil [5].
The rodent parasite Nippostrongylus brasiliensis (Nb) has
proven a valuable laboratory model for nematode migra-
tion through the host body. In mice, L3 larvae injected
into the skin migrate via the lungs to the small intestine,
where the parasites develop into adults [6]. Peak abun-
dance of Nb larvae in the lung occurs around 2 days post-
infection (pi) in many strains of mice [7]. The lung migra-
tory stage of Nb is associated with a strong local Type 2
inflammatory response that includes T-helper (Th)2 cells,
eosinophils and basophils [8,9]. Alternatively-activated
macrophages (AAMφ) have also been identified as a major
component of the pulmonary response to Nb infection
[10,11]. AAMφ are characterised by IL-4/IL-13-dependent
production of chitinase and Fizz/resistin family members
(ChaFFs) including RELMα (also known as Fizz1), the
chitinase-like protein Ym1, and Arginase-1 [12-15], and
all three proteins are consistently observed in the Nb
infected lung [10,11,16-18]. Arginase-1 is the counter-reg-
ulatory enzyme to iNOS and can thus act to suppress NO
production and Type 1 effector function. Arginase-1 also
has well documented roles in tissue repair [19,20] and has
recently been implicated as an anti-nematode effector
molecule [21]. The functions of RELMα and Ym1 are less
well understood but, like Arginase-1, they have been
strongly implicated in the response to injury [22-24] and
have putative roles in the repair process, including extra-
cellular matrix deposition and angiogenesis [25,26].
However, recent data have shown that RELMα and macro-
phage-derived arginase can also negatively regulate Th2
effector responses and thus limit the pathology associated
with overzealous repair [27-29].
Although not formally proven, the association of Argin-
ase-1, RELMα, and Ym1 with the tissue repair process sug-
gests that in the context of nematode infection, ChaFFs,
potentially produced by AAMφ, may be required to
orchestrate the repair of damage caused by larval migra-
tion in order to restore lung integrity. Two recent papers
have highlighted the potential for Nb migration to dam-
age the lung with potentially long term consequences
[16,18]. Both studies document haemorrhaging of lung
tissue and sustained increases in airway hyper-responsive-
ness. A striking novel observation in these studies is that
Nb causes disruption of the alveolar architecture that is
consistent with pulmonary emphysema many weeks after
infection. Dysregulated, AAMφ-mediated repair of the
damage caused by the nematodes may be responsible for
such detrimental outcomes [16].
Helminths with lung migratory stages are often co-
endemic with Type 1-inducing parasites such as malaria
[30-32]. Given the potential for cross-regulation between
Type 1 and Type 2 immune responses, we wished to use
mouse models to investigate the consequences of co-
infection for the pulmonary Type 2 immune responses
induced by nematode migration. We chose to focus on Nb
and a rodent malaria, Plasmodium chabaudi chabaudi (Pcc),
that induces a potent Type 1 immune response and non-
lethal infection [33]. We challenged hosts simultaneously
with these two acute infections, thus demanding polar-
ized, conflicting immune responses at the same point in
time. In addition, we expected Nb-Pcc co-infection to
induce conflicting responses in the same anatomical loca-
tion, because malaria-infected red blood cells (RBCs) of
many species, including Pcc, adhere to endothelial cells of
the microvasculature of the lung [34-36]. Furthermore,
malaria itself has been shown to cause lung injury [37,38].
Thus, we expected the lung and draining (thoracic) lymph
nodes to be potential sites of strong interactions between
Nb and Pcc. The idea that helminth-malaria co-infection
may impose Type 1-Type 2 immunological conflict is not
new [30], nor is the idea that parasitic co-infection may
alter the severity of pulmonary disease [39,40], but our
emphasis on the consequences of malaria for pulmonary
Type 2 responses has not previously been explored.
Using these model systems, we assessed production of the
ChaFFs, RELMα and Ym1 as primary read-outs of the Type
2 effector response in the lung. We also examined thoracic
lymph node (TLN) cytokine profiles, parasitology and sys-
temic pathology, to set the co-infected lung in its whole-
organism context. By 7 days pi, malaria infection had sig-
nificantly reduced the expression of ChaFFs in the lungs of
co-infected animals relative to those with Nb only. This
reduction correlated with changes in Th2 cytokines in the
TLN, with co-infected mice producing significantly less IL-
13, IL-10 and IL-5 than mice infected with Nb only. Pcc co-
infection thus reduced the extent of pulmonary Type 2
activation and Th2 polarisation in response to Nb. Future
long-term experiments (up to a year in duration [16]) in
the co-infection model established here will explore how
helminth migration may interact with malaria infection to
affect chronic lung pathology.Page 2 of 19
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Nb infection caused loss of both body mass and RBC 
density but ameliorated Pcc infection
To investigate pulmonary immune polarization during
acute helminth-malaria co-infection, on day 0 we infected
female BALB/c mice with 200 Nb L3 larvae, in the pres-
ence or absence of co-infection with 105 Pcc-infected
RBCs. Our first goal in developing this model was to char-
acterise the systemic pathology induced by each infection
and co-infection. We thus measured body mass (to the
nearest 0.1 g), RBC density (billions/mL), and malaria
blood parasitaemia daily. We also assessed the presence of
malaria parasites in lung tissue of mice culled at 3 or 7
days pi.
Consistent with previous reports in rats [41], we found
that Nb infection induced loss of body mass in mice dur-
ing the first week of infection: Nb-infected mice reached a
significantly lower minimum body mass than mice with-
out Nb (Fig. 1A; F1,110 = 21.1; P < 0.0001). This amounted
to a mean loss of 0.7 g, or ~3% of body mass, and was
observed regardless of malaria co-infection. No further
changes in body mass among groups achieved statistical
significance, though Pcc-infected mice showed an
expected dip in weight around day 10 that was unaltered
by Nb.
In addition to weight loss, Nb infection caused RBC den-
sities to be reduced by ~5% (Fig. 1B; effect of Nb on min-
imum RBC density to 7 days pi: F1,110 = 8.8; P = 0.0037).
Unsurprisingly [33], Pcc also caused loss of RBCs by 7
days pi (F1,110 = 40.2; P < 0.0001). Between days 7 and 20
pi, Nb-induced RBC loss resolved, but Pcc induced further
loss of RBCs - up to 60% of original density (Fig. 1B; F1,110
= 385.4; P < 0.0001). However, this was slightly (~5%)
but significantly ameliorated by Nb co-infection (Fig. 1B;
t110 = 4.2; P = 0.0003).
Consistent with this slight protective effect of Nb on RBC
loss during peak Pcc infection, Nb co-infection was associ-
ated with a modest reduction in Pcc blood parasitaemia,
as determined by microscopic examination of blood films
(Fig. 2A; maximum parasitaemia F1,62 = 4.13; P = 0.0465).
By real-time PCR, the number of Pcc genome copies per
75 mg lung homogenate sample was assessed in Pcc-
infected versus co-infected mice. Malaria parasites were
present in the lung of most animals examined at 3 days pi
and all animals at 7 days pi (Fig. 2B). At 3 days pi, which
is shortly after Nb parasites have migrated through the
lung [7] and coincident with the loss of body mass in Nb-
infected mice (Fig. 1A), co-infected mice had more Pcc
genome copies per lung sample (Fig. 2B; P = 0.010). This
could be due to enhanced Pcc adherence to the lung
endothelia [34] during Nb co-infection. However, by
gross examination we observed substantial haemorrhag-
ing in all Nb-infected mice at this time point and thus it is
also possible that leakage of blood into the lung tissue
increased the number of Pcc parasites in day 3 samples. At
7 days pi there was no significant difference between the
Pcc and the Nb+Pcc groups.
Gut nematode burden at 3 days pi varied between experi-
ments: for example, Nb+Pcc and Nb mice bore 56+10 and
35+9 adult nematodes, respectively, in experiment one,
versus 6+4 and 1+1 nematodes in experiment two. Such
variation has been previously reported [7] and in the
present study is likely to be due to the very rapid infection
kinetics typically observed for our Nb strain, which is not
mouse-adapted (e.g., no nematodes remain in the gut at 5
days pi). A difference of a few hours in Nb injection times
on day 0 and/or in gut sampling times on day 3 could
therefore lead to the differences in nematode burden that
we observed. Indeed, two lines of evidence suggest that
the number of Nb larvae moving through the lung was
much more consistent than the observed gut burdens.
First, there were no significant differences among experi-
ments in the amount of Nb-induced weight loss (P~0.2)
nor RBC loss (P~0.4). Furthermore, Type 2 immunologi-
cal readouts were extremely consistent among experi-
ments. For example, TLN production of IL-4, IL-5, and IL-
13 in response to Nb infection did not differ significantly
among experiments (P~0.9, 0.8, and 0.9, respectively).
Still, in order to be certain that experimental variations
were not confounding any of our conclusions, we control-
led for experiment in all statistical analyses of combined
data (as described in Methods).
Nb-induced ChaFFs in the lung peaked around 5-7 days pi
Before we undertook studies of Type 2 immune responses
in the lung during co-infection, we assessed the time
course of Nb-induced pulmonary expression of ChaFFs.
Previous work has mainly focused on ChaFF mRNA
expression in the lungs [10,11,16,17]. We wished to also
ascertain protein expression in situ after Nb infection, to
more closely determine the location of these proteins in
vivo. Female BALB/c mice were infected with 200 Nb-L3s,
or injected with PBS as a control, and RELMα and Ym1
protein levels were determined in BALF (via Western
blots) and lungs (via IHC) at days 3, 5, 7, 15, 20 and 26
pi, to reflect the early events, peak Th2 time point and res-
olution stages of Nb infection [9].
RELMα and Ym1 were both detected in BALF at 3 days pi,
and rose to a peak around 5-7 days pi (Fig. 3A, B). Expres-
sion of both proteins dropped off by days 20-26 pi. Histo-
logical analysis of Ym1-stained lung sections from
infected mice illustrated this peak, with an increase in the
intensity and area of anti-Ym1 staining at 5-7 days pi (Fig.
3E, F). These representative micrographs also show thePage 3 of 19
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Pathology, measured as loss of body mass (A) and red blood cell density (B)Figure 1
Pathology, measured as loss of body mass (A) and red blood cell density (B). Mice were infected with 200 Nb L3 lar-
vae and/or 105 Pcc-infected RBCs on day 0, then weighed daily to the nearest 0.1 g. Daily samples of blood were taken for flow 
cytometric analysis of RBC density. (A) Nb infection induced significant loss of body mass during the first week of infection 
(lower minimum body mass than mice without Nb; P < 0.0001). (B) Nb also induced significant loss of RBCs that week (lower 
minimum RBC density to 7 days pi than mice without Nb; P = 0.0037), whereas Pcc-induced RBC loss was mainly apparent dur-
ing the second week of infection (lower minimum RBC density to 20 days pi than mice without Pcc; P < 0.0001). Nb co-infec-
tion significantly ameliorated this (higher minimum RBC density in co-infected compared to Pcc-infected mice; P = 0.0003). 
Means ± SEM from combined results of 3 independent experiments (each with 4-9 mice per group per time point) are shown. 
The vertical dashed line indicates the two time periods for which minimum weight and RBC density were analysed: up to 7 
days pi, and 7-20 days pi, as described in Methods. The symbol * indicates statistical significance of the Nb main effect, and § 






BMC Immunology 2009, 10:60 http://www.biomedcentral.com/1471-2172/10/60influx of Ym1-positive inflammatory cells into the lung
tissue that was evident by day 7 - e.g., alveolar and peri-
bronchial inflammation. Of note, although infiltrating
cells were RELMα+ (data not shown) and Ym1+, epithelial
cells also appeared to be a major source of these mole-
cules. Reece et al. (2006) clearly demonstrate macro-
phages as sources of these proteins in the lung during Nb
infection but do not mention epithelial cells [11]. Our
data are more consistent with a recent study in which
RELMα was localized primarily to epithelial cells in Nb-
infected mice [29]. Further, several reports on inflamed
allergic (asthma model) and fibrotic (bleomycin- or gam-
maherpes virus-induced) rodent lungs, as well as our own
unpublished data, demonstrate expression of both Ym1
and RELMα by epithelial cells [26,42,43]. By 15-26 days
pi (Fig. 3G, H, I), Ym1 protein expression had returned to
near-background (Fig. 3C), with reduced inflammatory
influx and resolution of the thickened and disrupted epi-
thelial layer that was apparent at earlier time points. These
data are supportive of the idea that pulmonary activation
of AAMφ is a highly dynamic process [44].
Pcc changed the dynamics of expression of Nb-induced 
ChaFFs, especially 7 days pi
To assess the effect of Pcc co-infection on the dynamics of
Nb-induced pulmonary AAMφ and Type 2 epithelial cell
activation, we next analysed both mRNA and protein
expression of two ChaFFs, RELMα and Ym1, at a series of
time points during co-infection. We also measured local
mRNA expression of iNOS as a marker for Type 1 macro-
phage activation [19], which might be expected during
malaria [45]. Furthermore, we measured mRNA of Type 1
cytokines (IL-12p40, TNF-α, and IFN-γ), as well as mRNA
of IL-13, a key cytokine likely to drive production of Type
2 effector molecules such as the ChaFFs [12-15]. We chose
to examine the effect of malaria infection around the peak
of larvae-induced damage (i.e., ~day 3 pi) [7] and the time
of transition to adaptive Type 2 responses (i.e., ~days 5-7
pi) [9,11]. We also assessed a later time point well into the
adaptive immune phase: 20 days pi.
Analysis of ChaFF mRNA expression at 3, 5, 7 and 20 days
pi suggested that the strongest interactions between Nb
and Pcc-induced responses in lung tissue occurred 5-7
days pi (Fig. 4A, B). Indeed, because days 5-7 pi repre-
sented a time of strong ChaFF expression in Nb lung (Fig.
3) and day 7 pi coincided with the presence of Pcc there
(Fig. 2B), it is perhaps unsurprising that days 5-7 pi could
be the time of maximum effect of Pcc co-infection. At 3
days pi, there was a transient elevation of RELMα mRNA
in co-infected compared to Nb-infected mice (P = 0.0257)
that was reversed over the next few days: differences
between the groups were not significant at 5 days pi, but
RELMα gene expression was significantly reduced in co-
infected mice at 7 days pi (Fig. 4A; F1,25 = 7.5, P = 0.0113,
for combined analysis of experiments). Expression of
Ym1 mRNA was also significantly lower in co-infected
than Nb mice at days 5 and 7 pi (Fig. 4B: day 5 P = 0.0442;
day 7 F1,25 = 9.5, P = 0.005, for combined analysis of
experiments). In agreement with these observations, day 7
expression of Arginase-1 mRNA was significantly lower in
the lungs of co-infected mice than in mice that had Nb
only (data not shown; F1,24 = 7.7, P = 0.0104). Further-
more, ChaFF expression is known to be driven by engage-
ment of IL-4Rα [24] by IL-4 and/or IL-13; accordingly, IL-
13 mRNA expression in the lungs of co-infected mice was
significantly reduced compared to Nb-infected mice at 5
days pi (Fig. 4C: P = 0.0169). This suggests that suppres-
sion of IL-13 by Pcc may be responsible for the reduced
ChaFFs in co-infected mice. At 20 days pi, mRNA expres-
sion for RELMα (P = 0.0101) was slightly elevated in co-
infected relative to Nb-only mice, but ChaFF and IL-13
mRNA expression had otherwise largely returned to back-
ground levels. Throughout this time course, Pcc-infected
and uninfected animals expressed little or no mRNA for
the ChaFFs.
In support of the mRNA data, when we analysed protein
expression in lung BALF using Western blotting, we saw a
significant day 7 pi reduction of both RELMα (Fig. 5A;
F1,25 = 8.7, P = 0.0067, for analysis of combined experi-
ments) and Ym1 (Fig. 5B; F1,25 = 7.7, P = 0.0104, for anal-
ysis of combined experiments) in co-infected mice
compared to Nb-infected mice. By day 20 pi, the pattern
had reversed, with co-infected mice expressing more
RELMα (P = 0.0398) and Ym1 (P = 0.0171) than Nb mice.
ChaFF expression in Pcc-infected mice did not differ from
near-null expression in uninfected control mice (Fig. 5A,
B). Importantly, BAL cell counts and cellular composition
did not differ significantly among groups at any time-
point. There was a non-significant elevation in total num-
bers of cells in co-infected mice at 3 days pi and in Nb
mice at 5 days pi, which might partly explain the elevation
in ChaFFs at these early timepoints. However, any appar-
ent differences were entirely absent from the 7 and 20 day
BAL samples. Therefore, the observed effects on ChaFF
protein expression are unlikely to be due to differences in
cellular makeup alone, particularly at 7 and 20 days pi.
Further, the inflammatory cells may not be the major
source of CHaFF proteins in lavage fluid. The pattern and
intensity of epithelial cell staining (see Fig 6C) suggests
that these cells may be largely responsible for the changes
in mRNA and BALF protein.
IHC scoring of lung sections further confirmed these
dynamics. At both day 5 pi and day 7 pi, the intensity of
RELMα (Fig 6A) and Ym1 (Fig 6B) staining in the lungs of
co-infected animals was reduced compared to Nb mice,
though the RELMα difference did not achieve statistical
significance at day 7 (day 5: RELMα P = 0.0056; Ym1 P =Page 5 of 19
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Malaria parasites in the blood (A) and lungs (B) of Pcc-infected and co-infected miceFigu e 2
Malaria parasites in the blood (A) and lungs (B) of Pcc-infected and co-infected mice. (A) Co-infected mice 
(Nb+Pcc) had a lower peak proportion of parasitized RBCs than Pcc-infected mice did (P = 0.0465), as determined by 1000× 
microscopic examination of Giemsa-stained thin blood films. Means ± SEM from combined results of 3 independent experi-
ments (each with 4-9 mice per group per time point) are shown. (B) Co-infected mice harboured greater numbers of Pcc 
genome copies per lung sample than Pcc mice at 3 days pi (P = 0.01), as assessed by real-time PCR of lung homogenates 
(derived from 75 mg lung) using MSP-1 specific primers. Genome copies were apparent in both Pcc infected groups at 7 days pi 
and the copy numbers no longer differed significantly between groups. This experiment included 4-7 mice per group. The sym-
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resentative micrographs from day 7 pi show the reduced
intensity of RELMα staining in co-infected animals rela-
tive to Nb mice and no RELMα staining in Pcc mice (Fig.
6C). No differences among groups were detected by IHC
at days 3 or 20 pi. Therefore, the expression pattern of
ChaFF protein in situ was largely in agreement with mRNA
in whole lung tissue (Fig. 4) and protein expression in the
BALF (Fig. 5). As discussed above for the time course of Nb
infection (Fig. 3), although Ym1+ and RELMα+ macro-
phages were present in lung IHC sections, the predomi-
nant cell type expressing these molecules appeared to be
epithelial cells. Furthermore, lung macrophages in this
system do not appear to become classically activated, as
assessed by lung mRNA for iNOS and IL-12p40, which
were not detectable in any mice at any time point, and
TNF-α, which was detectable but at low levels that did not
differ among groups (data not shown). However, IFNγ
was elevated in the lung tissue of all Pcc infected mice,
regardless of Nb co-infection, at day 7 pi (Fig. 7).
Cytokine production in local LN largely mirrored 
pulmonary ChaFF expression
To assess whether pulmonary ChaFF patterns corre-
sponded to immune responses in the draining thoracic
lymph node (TLN), we performed in vitro culture of TLN
Time course of protein expression of ChaFFs in Nb infected lungsF gure 3
Time course of protein expression of ChaFFs in Nb infected lungs. Western blot analysis of lung lavages harvested at 
different time points post Nb infection (4 Nb mice per timepoint) suggested that the secretion of ChaFFs RELMα (A) and Ym1 
(B) peaked around 5-7 days post infection. Data are expressed as percentage of a positive control sample (pooled lung lavages 
of three Nb-infected mice). Representative photomicrographs from Nb-infected lung tissue sections stained histologically for 
Ym1 at the indicated time points, plus an uninfected control lung (C), illustrate peak expression of brown Ym1 staining of epi-






























Alveolar macrophages Bronchial epithelium
Day 15                       Day 20                                    Day 26
RELM                           Ym1Page 7 of 19
(page number not for citation purposes)
BMC Immunology 2009, 10:60 http://www.biomedcentral.com/1471-2172/10/60cells, in media alone or with antigen or ConA. At 3 and 5
days pi, there were no significant differences in superna-
tant cytokine concentrations among infection groups.
However, by 7 days pi, differences among the groups were
apparent, as outlined below. No antigen-specific
responses were observed (i.e., no cytokines in excess of
spontaneous secretion in media alone) until 20 days pi
(discussed below). Spontaneous and ConA-induced
cytokines exhibited identical patterns, though spontane-
ous responses were of lower magnitude.
At 7 days pi, Nb infection in singly as well as co-infected
mice was associated with significantly elevated ConA-
induced production of IL-4, IL-13, IL-5, and IL-10 com-
pared to uninfected and Pcc-infected mice (Fig. 8A, B, C,
D; all P for Nb main effect < 0.0001). Of interest, IL-6 and
sTNFR1 were also associated with Nb but not Pcc infection
(Fig. 8E, F; both P for Nb main effect <0.0001). TNF-α pro-
duction did not vary among infection groups (Fig. 8G),
but Pcc infection was associated with significantly ele-
vated IFN-γ production compared to uninfected and Nb-
infected mice (Fig. 8H; P for Pcc main effect <0.0001). To
our knowledge, TLN polarization by systemic malaria
infection has not been previously reported. The Th1 bias
of the observed response to Pcc was unsurprising.
Co-infected mice differed from singly-infected mice in
ConA-induced production of some of these cytokines. For
example, IL-13, IL-5, and IL-10 production were signifi-
cantly reduced in co-infected compared to Nb-infected
animals (Fig. 8B, C, D; t61 = 7.3, 18.8, 8.1 and P = 0.011,
0.0001, 0.007, respectively), while IFN-γ production was
ChaFF and IL-13 mRNA expression in the lungs of Nb, Pcc and co-infected miceFigure 4
ChaFF and IL-13 mRNA expression in the lungs of Nb, Pcc and co-infected mice. Real-time RT-PCR of mRNA from 
lung tissue harvested at 3, 5, 7 or 20 days pi showed that the effect of Pcc on Nb-induced expression of RELMα (A) and Ym1 
(B) changed over time. RELMα was transiently elevated in co-infected (Nb+Pcc) compared to Nb mice at 3 days pi (P = 0.0257), 
but expression of mRNA for RELMα (A), and Ym1 (B) was then found to be significantly lower in the lungs of Nb+Pcc mice 
than in Nb mice by 7 days pi (RELMα, P = 0.0113; Ym1, P = 0.005). IL-13 mRNA expression (C) largely mirrored this pattern, 
as it was significantly reduced in Nb+Pcc mice compared to Nb mice at 5 days pi (P = 0.0169). At 20 days pi, however, RELMα 
(A) was again significantly elevated in Nb+Pcc relative to Nb mice. (P = 0.01) Data are expressed as percentage of positive con-
trol samples (for RELMα and Ym1, peritoneal macrophages of a mouse implanted with Brugia malayi adult parasites for 3 weeks 
[72]; for IL-13, spleen of an MHV-68 infected IFNγR-KO mouse [63]). Bars indicate mean ± SEM of 2 combined independent 
experiments, each with 4-9 mice per group per timepoint. The symbol ¶ indicates significance of the difference between co-
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BMC Immunology 2009, 10:60 http://www.biomedcentral.com/1471-2172/10/60reduced in co-infected compared to Pcc-infected animals
(Fig. 8H; t61 = 8.4 and P = 0.006). These results provide
evidence of cross-regulation between Th1 and Th2
immune responses in the local lymph node during the
first week of co-infection. This finding is consistent with a
wide range of studies of murine co-infection (reviewed in
[30,46]).
By 20 days pi, the overall strength of TLN cytokine
responses had waned, but antigen-specific responses were
detectable. Correcting for background (spontaneous)
secretion of cytokines in wells with media alone, antigen-
specific responses to crude helminth (Nb Ag) and recom-
binant malaria (MSP-119 Ag) antigens were each observed
for a subset of the cytokines measured (Fig. 9). For exam-
ple, Nb infection was associated with strong Nb Ag-spe-
cific IL-13 responses (Fig. 9A: P < 0.0001), regardless of
co-infection. Co-infection, however, had a significant
boosting effect on Nb Ag-specific IL-5 (Fig. 9B: P = 0.0025
for the comparison with Nb mice; P < 0.0001 for the com-
parison with Pcc mice). Co-infection was also associated
with significantly elevated MSP-119Ag-specific IL-6 (Fig.
9C: P = 0.0163 for the comparison with Nb mice; P =
0.0112 for the comparison with Pcc mice). TNF-α produc-
tion, though greater than background, did not differ sig-
nificantly among groups (Fig. 9D).
Discussion
Our primary aim in this study was to address the interplay
of two acute infections that place conflicting demands on
the host immune response, particularly in the lung. We
wanted to focus on Type 1-Type 2 cross-regulation rather
than any effects of regulatory T cells, so we opted for a
model of acute rather than chronic helminthiasis. In addi-
tion, although anatomical compartmentalization does
not preclude immunological interaction - for example,
gut-restricted helminths can induce a strong systemic Th2
bias [47] - compartmentalization can buffer the effects of
co-infection [48]. We thus chose murine infection models
that would pose an immunological conflict in anatomical
space as well as time post-infection (pi). The dynamics we
were investigating may have real life corollaries, because
nematode migration occurs in the lungs of over a third of
the world's human population [1,2], many of whom are
co-infected with malaria [31,32]. However, because both
of our murine models (Pcc and Nb) produce self-resolving
infections, the effects of co-infection on anaemia and on
pulmonary immunology reported here cannot be firmly
Western blot analysis of ChaFF protein expression in BALF of Nb, Pcc and co-infected miceFigure 5
Western blot analysis of ChaFF protein expression in BALF of Nb, Pcc and co-infected mice. Lung lavages har-
vested at days 3, 5, 7 and 20 pi indicated that the ChaFF proteins RELMα (A) and Ym1 (B) exhibited temporal dynamics that 
were similar to those observed for mRNA expression in lung tissue (Fig. 4). In particular, expression of both proteins was sig-
nificantly lower in the lungs of co-infected (Nb+Pcc) than in Nb mice at 7 days pi (RELMα P = 0.0067 and Ym1 P = 0.0104). This 
pattern had reversed by 20 days pi, with increased ChaFF protein expression in Nb+Pcc compared to Nb mice (RELMα P = 
0.0398 and Ym1 P = 0.0171). Data are expressed as percentage of a positive control sample (pooled lung lavages of three Nb-
infected mice). Bars indicate mean ± SEM of combined results of 2 independent experiments, each with 4-9 mice per group per 
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Immunohistochemical analysis of ChaFF protein expression in the lungs of Nb, Pcc and co-infected miceFigure 6
Immunohistochemical analysis of ChaFF protein expression in the lungs of Nb, Pcc and co-infected mice. Pro-
tein expression in lung sections corroborated BALF concentrations of ChaFF proteins observed around 7 days pi, as illustrated 
by days 5 and 7 pi staining intensity scores for RELMα (A) and Ym1 (B) as well as representative micrographs (at increasing 
magnification) of day 7 pi slides stained for RELMα (C). Down-regulation of ChaFFs was observed in co-infected mice (Nb+Pcc) 
compared to Nb mice; differences were significant for both RELMα and Ym1 at 5 days pi (RELMα P = 0.0056 and Ym1 P = 
0.0153) and for Ym1 at 7 days pi (P = 0.0171). Scores were obtained by analyzing bronchial epithelium in ten fields per mouse 
using a scoring system described in Methods. The whisker-and-box graphs with minimum and maximum values depict results 
from a representative experiment with 4-9 mice per group. The symbol ¶ indicates significance of the difference between co-
infected and Nb mice (P values included above and in Results text).
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term co-infection studies are performed.
We quantified the health of mice in our experiments using
two measures that have proven informative during Pcc
infection [49] and Pcc-nematode co-infection [50]: body
mass and RBC density. To our knowledge, this is the first
report demonstrating that murine Nb infection has a neg-
ative impact on both parameters, although reduced
weight gain in young Nb-infected mice has previously
been reported [40]. Nb caused a statistically significant,
transient ~3% loss of body mass from approximately 2-4
days pi, and in other experiments using a higher dose
(500 L3s), mice lost closer to 10% of their starting body
mass (unpublished data). Migration of Nb larvae through
the lungs has previously been shown to cause two spells
of inappetance and thus weight loss in rats, one associated
with migration of larvae and the other with establishment
of adults in the gut [41]. We detected only one period of
loss of body mass; mice may be spared the second spell
given the brief survival of adult Nb in mice, particularly for
parasite strains, such as ours, that are not mouse-adapted.
We also observed a transient loss of RBC density in Nb-
infected mice. It was rather surprising that this effect -
most likely caused by haemorrhaging of the lung follow-
ing larval migration - was detectable at the systemic level.
This suggests that the capillary damage and ingestion of
RBCs by alveolar macrophages following lung migration
of Nb [11,16] are associated with considerable blood loss.
A diverse range of outcomes is possible when helminths
and malaria co-infect a host. Co-infected mice in our
study experienced two periods of RBC loss in quick succes-
sion - first Nb-induced and then Pcc-induced. However,
they had slightly higher RBC densities than Pcc-infected
mice did, at the time of most severe malarial disease. This
was associated with a small reduction in malaria parasi-
taemia in the blood. These results contrast with several
studies of helminth-malaria co-infection in mice, in
which malaria parasitemia was increased [51-54], and/or
malarial symptoms exacerbated, in at least some groups of
co-infected mice [50-55]. For example, in contrast to the
lethal inflammatory liver disease recently described in
mice simultaneously co-infected with Heligmosomoides
polygyrus and Pcc [55], we observed subtle amelioration of
malarial disease and no deaths. This disparity in the sever-
ity of co-infection could be due to the fact that we worked
with a different mouse strain (BALB/c versus Helmby's
C57BL/6) as well as a different helminth species that
migrates differently through the host body. However, we
detected an elevation in MSP-119-specific IL-6 due to co-
infection, so it is possible that the emergent IL-17/IL-23
axis described by Helmby [55] may likewise be involved
in our co-infection system, though not in organs that neg-
atively impact short-term survival. Indeed, the mecha-
nisms underlying the slightly protective effect of Nb
observed here are not yet clear. We are investigating possi-
ble immunological causes of this protection, including
innate mechanisms such as IFN-γ+ NK cells [56] and adap-
tive mechanisms such as cytophilic antibody isotypes [33]
that could promote malaria clearance; either might be
altered by acute Nb co-infection. However, it is also possi-
ble that lower parasitaemia might be the consequence of
the RBC density changes induced by Nb, as previous co-
infection studies have shown that helminths can limit
RBC availability to malarial parasites and thereby cap
their replication (e.g., [57]). Control of microparasites by
Th1 immunity and by RBC limitation are not mutually-
exclusive possibilities [58] and both might be operating in
our model system. Finally, it is possible that the sequestra-
tion habits of Pcc parasites [59] are altered by Nb. These
mechanisms remain to be investigated.
Our results largely resemble those reported for other Nb-
microparasite pairings. For example, during co-infection
of mice with Nb and either Toxoplasma gondii [60] or
Chlamydophila abortus [61], significantly reduced Th2
responses (compared to mice with Nb infection) have
been observed, independent of the interval between infec-
tions [60,61]. These data suggest that Pcc is not the only
Lung mRNA for the Type 1 cytokine IFN-γ at 7 days piFigure 7
Lung mRNA for the Type 1 cytokine IFN-γ at 7 days 
pi. Real-time RT-PCR of mRNA from lung tissue harvested 
at 3, 5, 7 or 20 days pi using primers for Type 1 markers 
iNOS, IL-12p40, TNF-α, and IFN-γ were largely negative. For 
example, no iNOS nor IL-12p40 was detected in any mice, 
and although TNF-α was detected at low levels, its expres-
sion did not differ among groups of mice. At 7 days pi, how-
ever, IFN-γ was significantly upregulated in all mice with Pcc 
infection, with or without Nb co-infection, as depicted here. 
Data are expressed as percentage of a positive control sam-
ple (peritoneal macrophages of a thioglycolate-injected 
mouse [10]). Mean ± SEM from a representative experiment 









)Page 11 of 19
(page number not for citation purposes)
BMC Immunology 2009, 10:60 http://www.biomedcentral.com/1471-2172/10/60
Page 12 of 19
(page number not for citation purposes)
ConA-induced cytokine release in TLN lymphocyte recall assaysFigure 8
ConA-induced cytokine release in TLN lymphocyte recall assays. Cytokine concentrations in supernatants of ConA-
stimulated TLN cells harvested at day 7 pi were measured with cytometric bead arrays. Groups did not differ in cytokine pro-
duction at 3 or 5 days pi, and no antigen-specific responses were detected until 20 days pi. Data on day 7 pi IL-4 (A), IL-13 (B), 
IL-5 (C), IL-10 (D), IL-6 (E), sTNFR1 (F), TNF-α (G), and IFN-γ (H) production are shown. In these data, statistically significant 
down-regulatory effects of co-infection (Nb+Pcc) were found for IL-13 (P = 0.011), IL-5 (P = 0.0001), IL-10 (P = 0.007), and IFN-
γ (P = 0.006), compared to relevant single-infection groups. Bars indicate mean ± SEM from 3 combined experiments, each with 
4-9 mice per group. The symbol ¶ indicates significance of the difference between co-infected and Nb mice, while § indicates 
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Antigen-specific responses in TLN lymphocyte recall assaysFigure 9
Antigen-specific responses in TLN lymphocyte recall assays. Cytokine concentrations in supernatants of TLN cells 
that were harvested at day 20 pi and then stimulated with antigen were measured with cytometric bead arrays. Nb Ag, a crude 
Nb adult lysate, and recombinant Pcc clone AS merozoite surface protein, MSP-119, were used as antigens in vitro. Although all 
cytokines shown in Figure 8 were measured, only IL-13 in response to Nb Ag (A), IL-5 in response to Nb Ag (B), IL-6 in 
response to MSP-119 (C), and TNF-α in response to MSP-119 (D) were above levels of spontaneous secretion. These figures 
thus depict antigen-specific cytokine (in ng/ml above background). Statistically significant differences among groups included 
increased NbAg-specific IL-13 in all Nb mice (P < 0.0001), increased Nb Ag-specific IL-5 in co-infected (Nb+Pcc) mice compared 
to both Nb (P = 0.0025) and Pcc mice (P < 0.0001), and increased MSP-119-specific IL-6 in Nb+Pcc compared to both Nb (P = 
0.0163) and Pcc mice (P = 0.0112). Bars indicate mean ± SEM for 4-8 mice per group. The symbol ¶ indicates significance of the 
difference between co-infected and Nb mice, while § indicates significance of the difference between co-infected and Pcc mice (P 
values included above and in Results text).
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infection. Mycobacterium bovis BCG co-infection, however,
does not significantly impact Nb-induced IL-4 in the
mesenteric lymph nodes [62]; it would be of interest to
know whether those lung-dwelling microparasites might
have had similar effects to Pcc on Th2 responses, had they
been measured in the TLN. Reported effects of Nb on the
course of microparasite infections are likewise mixed:
densities of T. gondii [60] and M. bovis BCG [62] are unaf-
fected by the presence of the nematode, while C. abortus
density increases dramatically [61]. Interestingly, the con-
current presence of influenza virus with migrating Nb lar-
vae in the lung exacerbates the severity of lung disease
compared to mice with influenza alone [40]. A two-week
delay between Nb infection and influenza infection, or
replacement of Nb with H. polygyrus, eliminates the added
pathology, suggesting that the simultaneous presence of
larvae and virus in the lungs is required [40]. Such may
also be the case for Pcc-Nb co-infection. The Nb-influenza
study did not include immunological measurements, so
the role of the immune system in generating the observed
pattern is not known. Indeed, this comparison illustrates
that many details of anatomical location and parasite life
cycles, as well as immunological interactions, must be
taken into account to explain the diverse outcomes of
helminth-microparasite co-infections [30,46].
Our most novel finding is that malaria infection has the
capacity to modulate the host's pulmonary Type 2
response to nematode migration. However, the long-term
impact of the altered Type 2 response is not possible to
predict, because the function of Type 2 immunity in this
setting is not yet fully understood. There are at least three
potential outcomes of a helminth-induced Type 2
response in the lung. First, it may contribute to protection
against incoming larvae [6]. Second, Type 2 responses are
likely to be involved in repairing the damage that is
inflicted by migrating parasites. Third, as recent studies
have shown [5,16,18], lung migration and the associated
Th2 responses have the potential to cause long-term lung
pathology. Appropriate repair versus lung malfunction are
likely to be flip sides of the same coin. Indeed, although
ChaFFs and Arginase-1 are implicated in tissue repair,
they are also associated with fibrosis, an overzealous
repair process [19,24,43,63-65] (see also review by Wynn
[66]). Predicting the effect of Pcc co-infection on long
term Nb-induced lung disease is further complicated by
recent data that suggest both Arginase-1 and RELMα can
negatively regulate Th2-mediated pathology [27-29]. By
this logic, inhibition of these molecules by malaria co-
infection may ultimately exacerbate Th2-mediated lung
damage.
However, our data suggest that the effect of malaria on
ChaFF expression is not direct but rather via reduced Th2
cytokines. The effect of Pcc on Nb-induced ChaFFs was not
apparent until 7 days pi, when the extent of the increase
in ChaFF expression was inhibited by co-infection. This
was correlated with differences in cytokine production in
lymphocyte recall assays, suggesting that changes in
ChaFF expression were driven by changes in the T lym-
phocyte populations after the onset of the adaptive Th2
immune response (around 5 days pi, as shown in Nb-
infected IL-4 reporter mice [9]). A role for adaptive immu-
nity is further supported by work showing that SCID mice
are not able to sustain AAMφ responses in the lung follow-
ing Nb infection [11], and a demonstrated requirement
for T cells to sustain the AAMφ response in a mouse peri-
toneal infection model [24]. Remarkably, in SCID mice,
in the absence of T cells and AAMφ, the Nb-induced cellu-
lar infiltrate does not resolve [11]. The capacity of malaria
to inhibit the transition to a full Th2 response by 7 days pi
may likewise be detrimental to full resolution of the
inflammatory response, a step necessary for appropriate
tissue repair [67,68]. By day 20 pi, however, the residual
Th2 responses in co-infected mice were as high as, or even
higher than, in Nb-only mice. In support of this, day 20
antigen-specific IL-5 responses were particularly high in
co-infected animals. Thus Pcc infection may protect
against airway hyper-responsiveness through a reduction
in peak Th2 activation, or else exacerbate it due to sus-
tained Th2 activity. Transient passage of Nb larvae
through the lung inflicts lasting damage [16,18]. Whether
transient impairment of pulmonary Th2 responses by
malaria co-infection also has lasting effects needs to be
investigated experimentally.
A perhaps surprising finding in our study was the appar-
ent absence of classical macrophage activation in the lung
despite the clear presence of malaria parasites: we did not
detect iNOS, IL-12p40 nor elevated TNF-α mRNA in lung
tissue of Pcc-only or co-infected mice at any time point.
One could argue that malaria parasites stay in the lung
microvasculature and do not cross into tissue. However,
this is unlikely to be the case, given the extensive lung
damage due to Nb in co-infected mice, as well as evidence
that malaria merozoites can be found dispersed in the
lung [34]. Furthermore, IFN-γ mRNA was detectable in the
lung of all Pcc mice regardless of co-infection, suggesting
that lymphocytes were activated, perhaps by innate activa-
tion of NK or γδ T cells. The most likely explanation for
the failure to detect classical macrophage activation may
be that lung macrophages, which are exposed daily to
inhaled microbes, have a remarkably high threshold for
activation even in the presence of IFN-γ and microbial
stimuli [69].
As with any laboratory model, it is important to acknowl-
edge the potential disconnection between natural co-
infections and the experimental systems and designs usedPage 14 of 19
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doses at which they were administered, and the fact that
we have only studied primary and self-resolving (rather
than secondary and/or chronic) infections. Permutation
of any of these parameters is likely to quantitatively, if not
qualitatively, alter outcomes. For example, repair proc-
esses might readily keep pace with lung damage when the
rate of exposure to nematode larvae is low, unlike in most
experimental models. We used a relatively low dose of L3
larvae (200 per mouse while others use ~500 [16,18] or as
many as 750-1000 [60-62]) but still exceeded natural
exposure levels. Furthermore, larval helminths and
malaria parasites are unlikely to arrive in the lung within
a few days of each other in nature, and it may be that pre-
existing malaria would have had a different effect on pul-
monary Type 2 responses to Nb migration, particularly if
malaria parasites do not remain long in the lung. Indeed,
the most likely natural exposure scenario may be chronic
malaria infection into which helminth larvae are "trick-
led" [32], but experimental studies that mimic this sce-
nario have yet to be carried out. Nonetheless, lung
dysfunction is seen as a consequence of helminth migra-
tion [4,5] and both acute and persistent malaria infection
[38] in people, so high-dose experimental Nb studies in
which long-term lung pathology can be observed [16,18],
combined with simultaneous malaria exposure, may pro-
vide useful models for disease states in people.
Conclusion
With the experiments reported here, we have established
an acute laboratory model of helminth-malaria co-infec-
tion that will be suitable for future work exploring the
details of how Type 1 inducing co-infections affect long-
term, Type 2-mediated repair of the damage caused by
migrating nematodes. Recently developed models of
malaria-induced lung damage (e.g., [37]) might be ana-
lysed in animals co-infected with Nb. Corroborative stud-
ies in human populations may also be feasible. Like
migratory helminthiases [3], severe falciparum malaria is
associated with detectable lung injury, as measured by
spirometry and clinical symptoms [38]. A study like
Brooker et al's analysis of whether the anaemia of hook-
worm and malaria are additive during co-infection [32]
that used spirometry to assess the pulmonary health of
malaria-infected, A. lumbricoides- or hookworm-infected,
and co-infected people could assess whether co-infection
exacerbates damage. Given the huge number of people
with such co-infections, it is possible that clinical studies
of malaria lung injury may gain insight from considering
the presence, however transient, of helminths in the lung.
Methods
Mice, parasites, experimental design, and monitoring
Specific pathogen free, 8-10 week old female BALB/c mice
(Harlan, UK) were maintained in individually ventilated
cages on diet 41b ad lib. Nippostrongylus brasiliensis (Nb)
was maintained by serial passage through Sprague-Daw-
ley rats, as described previously [70]. Cryopreserved Plas-
modium chabaudi chabaudi (Pcc) parasites of clone AS were
passaged through two generations of donor BALB/c mice
and inoculated into experimental mice as described previ-
ously [50]. The four co-infection experiments used a fac-
torial design, with uninfected controls, Pcc-infected, Nb-
infected, and co-infected mice. On day 0, 200 Nb L3 larvae
and/or 105 Pcc-infected RBCs were injected subcutane-
ously and intraperitoneally, respectively. PBS and naïve
mouse RBCs served as sham injections for Nb and Pcc,
respectively; uninfected control animals received both
sham injections. RBC density, body mass, and malaria
parasites were then monitored daily, as described previ-
ously [50]. Briefly, RBC densities were measured by flow
cytometry (Beckman Coulter), body mass was recorded to
the nearest 0.1 g, and the proportion of RBCs parasitized
was counted in Giemsa-stained thin blood films (at
1000× magnification). Mice were then culled 3, 5, 7, or 20
days pi (4-9 mice per infection type per timepoint). Nb
parasite burden was assessed in the gastrointestinal tract
of culled mice. Intestines were placed in PBS, slit length-
wise and the contents rinsed into muslin-lined funnels set
over tubes containing PBS warmed to 37°C. Nematodes
were left to filter through for >2 hours and counted via
microscopy (at 40×). To elucidate the dynamics of Nb-
induced alternative activation in the lung, a separate
experiment was conducted for Nb only, with mice culled
3, 5, 7, 15, 20 or 26 days pi (4 Nb-infected mice per time
point). All experiments were carried out in accordance
with the animals (Scientific Procedures) Act 1986, and
were approved by the UK Home Office inspectorate and
institutional review committee.
Lung lavage and tissue sampling
Following terminal anaesthesia, tracheas were cannulated
and lungs lavaged with 1 mL PBS. Cannulae were pre-
pared from fine bore polythene tubing (Portex) and a 23
G needle. Following lavage, the left lung lobe was tied off,
cut at the bronchus, and placed in RNAlater (Ambion) for
mRNA extraction, while the right lobe was perfused in 4%
formaldehyde and embedded in paraffin for immunohis-
tochemistry. BAL cell concentrations were determined
using a Scharf Instruments Casy Counter. BALF was centri-
fuged at 1,200 g for 5 mins and stored at -20°C for protein
analysis by Western blot.
Immunohistochemistry
Expression of RELMα and Ym1 in lung sections was
assessed by indirect immunoperoxidase techniques.
Briefly, the paraffin embedded tissue sections were depar-
affinised and rehydrated. After high temperature antigen
unmasking (Vector Laboratories, UK), endogenous perox-
idase was quenched with aqueous 2% H2O2 (SigmaPage 15 of 19
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h with primary antibodies: rabbit anti-RELMα (0.25 μg/
mL; Peprotech) or rabbit anti-Ym1 (1/100; StemCell
Technologies) in antibody diluent (Dako Cytomation,
Denmark) at RT, followed by the secondary antibody
(goat anti-rabbit biotin, 1 mg/mL, Dako Cytomation,
Denmark). Peroxidase-labelled ABC reagent and DAB
substrate (Vector Laboratories, UK) were used for signal
visualisation. Finally, the sections were counterstained
with haematoxylin. RELMα and Ym1 staining intensities
were scored by two researchers, blinded to experimental
groupings, using a modification of a previously-published
lung inflammation scoring system [71]. For each mouse,
staining was assessed at 200× magnification for 10 fields.
Each field included correctly inflated lung tissue and a
complete transection of at least one bronchiole, blood
vessel and alveolar airway. Cytoplasmic staining strength
was scored in bronchial epithelial cells, infiltrating cells
and alveolar macrophages on a scale of 1-4 (1 = no stain-
ing, 2 = weak, 3 = moderate, and 4 = strong staining, using
a reference section of the same positive control sample
(lung of an Nb-infected mouse at 7 days pi). The percent-
age of positive cells in each of these compartments was
also scored on a scale of 1-4 (1 = none, 2<30%, 3 = 30-
60%, 4>60% positive cells). Average cytoplasmic and cell
positivity scores across the 10 fields were calculated.
Finally, the overall staining score for each mouse was cal-
culated by multiplying the average stain strength by aver-
age % positive cells. Control sections incubated with
antibody diluent followed by secondary antibody only, or
with normal rabbit serum alone, did not show any stain-
ing. Mouse lung pathology experts confirmed that stained
cell types were correctly identified. Photomicrographs of
representative sections were captured on a Zeiss Axioskop
microscope with QCapture Pro Software.
RNA isolation and real-time RT-PCR
RNA isolation from lung tissue was carried out using TRI-
zol (Invitrogen). After DNase treatment (10 U/mL
DNase1, Ambion), cDNA was synthesised using Moloney
murine leukaemia virus reverse transcriptase (Stratagene).
For quantification of Ym1, RELMα, Arginase 1, iNOS, IL-
12p40, TNF-α, IFN-γ and IL-13 mRNA, real-time RT-PCR
was performed using a LightCycler (Roche Diagnostics)
and primers reported previously [63]. For each gene, five
serial 1:4 dilutions of cDNA of a positive control sample
(for RELMα, Ym1 and Arg1, peritoneal macrophages of a
mouse implanted with Brugia malayi adult parasites for 3
weeks [72]; for IL-13, spleen of an MHV-68 infected
IFNγR-KO mouse [63]; or for iNOS and other Type 1
markers, peritoneal macrophages of a thioglycolate-
injected mouse [10]) were used in each reaction. Amplifi-
cation was quantified and normalised using β-actin as a
housekeeping gene. PCR reactions were carried out in 10
μl buffer containing 1 μl cDNA, 4 mM MgCl2, 0.3 μM of
each primer and the LightCycler-DNA SYBR Green I mix,
under the following conditions: 30 s denaturation at
95°C, 5 s annealing of primers at 55°C or 63°C (Ym1),
and 12 s elongation at 72°C, for 50 cycles. SYBR Green
fluorescence was monitored after each cycle at 86°C
(85°C for Ym1).
Real-time PCR to detect malaria in lung tissue
Real-time PCR for Pcc genomic DNA was carried out on
DNA extracted with phenol/chloroform from homoge-
nized lung tissue (stored in Trizol, Invitrogen; 75 mg tis-
sue/mL). PCR was performed on an ABI Prism 7000
(Applied Biosystems), with primers for merozoite surface
protein (MSP)-1 of clone AS, as described previously [73].
Western blot for Ym1 and RELM
20 μl BALF was mixed with sample buffer supplemented
with denaturing buffer (NuPage, Invitrogen), heat dena-
tured and resolved by SDS-PAGE using 4-12% gradient
Bis-Tris gels (NuPage, Invitrogen) followed by transfer
onto nitrocellulose membrane (Bio-Rad). Transfer and
loading intensity were assessed with Ponceau Red staining
(Sigma). After blocking with 0.05% Tween 20 in Starting
Block (Pierce), membranes were incubated overnight at
4°C with polyclonal rabbit anti-Ym1 [10] (0.12 ng/mL)
or rabbit anti-RELMα (0.2 μg/mL; Peprotech). After incu-
bation with HRP-conjugated goat anti-rabbit IgG (heavy
plus light chains; Bio-Rad; 1/2000), signal was detected
with chemiluminescence (ECL kit, Amersham Pharmacia
Biotech) and exposure to Hyper ECL film (Amersham).
Control blots were incubated with secondary antibody
only. Band intensity was determined with the FluorChem
SP imager system and software (Alpha Innotech, USA)
and expressed as percentage relative to a positive control
(pooled lung lavages of three Nb-infected mice) on each
blot.
Measurement of cytokine and cytokine receptor responses 
in local lymph nodes
Thoracic lymph node (TLN) cells were cultured at 5 × 105
cells per well, with 1 μg/mL Concanavalin A (ConA), 10
μg/mL adult Nb parasite extract, 1 μg/mL of recombinant
Pcc Merozoite Surface Protein MSP-119, or medium alone
at 37°C. After 72 h, supernatants were harvested. Concen-
trations of IL-4, IFN-γ, TNF-α, IL-5, IL-6, IL-10 and IL-13
were then measured using Cytometric Bead Array Flex Sets
(BD Biosciences), with slight modifications from manu-
facturer's instructions: 50 μl samples/standards were incu-
bated with capture beads (0.5 μl per sample per cytokine,
plus diluent to 25 μl) in darkness with shaking for 1 h at
RT. Plates were washed, spun at 200 g for 5 min, and then
incubated with 25 μl of PE-conjugated anti-cytokine anti-
bodies in darkness for 1 h. After washing and resuspen-
sion of beads, data were acquired on a FACSArray with
FCAP software (BD Biosciences). Soluble TNF Receptor-1Page 16 of 19
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ELISA, using 2 μg/mL capture antibody (clone MAB425),
200 ng/mL biotinylated detection antibody (BAF425),
and recombinant mouse sTNFR1 as standard (425-R1; all
from R&D Systems). Plates were blocked with 5% BSA in
TBS for 2 h at RT and washed with TBS/0.05% Tween
(TBST) before 50 μl samples were incubated overnight at
4°C. Plates were washed, incubated with detection rea-
gent for 2 h at RT, washed again, and then incubated with
streptavadin-HRP (Sigma Aldrich) at RT for 20 min. Plates
were washed again and developed with TMB SureBlue
substrate system (KPL 52-00-03). The reaction was
stopped after 30 min with 1 M HCl and read on a spectro-
photometer at 450 nm.
Statistical analysis
Most data were analysed with SAS System 9.1 mixed-
model analyses of variance (ANOVA) or covariance
(ANCOVA) [74] (see exceptions below). To meet the
homogeneity-of-variance assumption of such analyses,
data were logarithmically transformed. To account for
slight differences among experiments in, for example, the
magnitude of ConA-stimulated cytokine production,
experiment was included as a random factor in all models.
All significant effects of infection reported below have
therefore remained significant after controlling for effects
of experiment, if any. To account for differences among
mice in starting body mass or RBC density, day 0 values
were included as covariates. Pathology analyses focused
on animals that experienced the full 20-day course of
infection, and minimum body weight and RBC density
were analysed in two time frames: the first week pi, and
the entire experiment. In accord with the factorial design
of the experiments, Pcc and Nb infection were fit as fixed
factors. Wherever the interaction term was significant
(indicating a potential effect of co-infection), post-hoc t-
tests adjusted for multiple comparisons were run. A
Tukey-Kramer-corrected P < 0.05 was used as the cut-off
for significance. For relevant subsets of mice, an Nb fixed
factor was used to test whether co-infection altered Pcc
parasitaemia, while a Pcc fixed factor tested whether co-
infection altered expression of ChaFFs.
Following logarithmic transformation to meet the
assumptions of parametric statistical analysis, the ChaFF
time courses, IHC scores, and lung Pcc data were analysed
with unpaired t-tests in Prism 4 (Graph Pad Software, Ber-
keley, USA), with a two-tailed P < 0.05 designated as sig-
nificant. Only two groups were compared per dataset, as
specified in the Results section.
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